Log in to save to my catalogue

Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer

Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9701133

Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer

About this item

Full title

Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer

Publisher

United States: Massachusetts Medical Society

Journal title

The New England journal of medicine, 2022-06, Vol.386 (24), p.2261-2272

Language

English

Formats

Publication information

Publisher

United States: Massachusetts Medical Society

More information

Scope and Contents

Contents

The role of adjuvant chemotherapy in stage II colon cancer continues to be debated. The presence of circulating tumor DNA (ctDNA) after surgery predicts very poor recurrence-free survival, whereas its absence predicts a low risk of recurrence. The benefit of adjuvant chemotherapy for ctDNA-positive patients is not well understood.
We conducted a...

Alternative Titles

Full title

Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9701133

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9701133

Other Identifiers

ISSN

0028-4793,1533-4406

E-ISSN

1533-4406

DOI

10.1056/NEJMoa2200075

How to access this item